135 related articles for article (PubMed ID: 10943642)
1. Management of febrile neutropenia in low risk cancer patients.
Oppenheim BA; Anderson H
Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S63-9. PubMed ID: 10943642
[No Abstract] [Full Text] [Related]
2. Outpatient management of febrile neutropenia in children with cancer.
Holdsworth M; Hanrahan J; Albanese B; Frost J
Paediatr Drugs; 2003; 5(7):443-55. PubMed ID: 12837117
[TBL] [Abstract][Full Text] [Related]
3. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Ammann RA
Cancer; 2004 Apr; 100(7):1547; author reply 1547-8. PubMed ID: 15042693
[No Abstract] [Full Text] [Related]
4. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
5. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
[TBL] [Abstract][Full Text] [Related]
6. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
Heuser M; Ganser A; Bokemeyer C; ; ;
Semin Hematol; 2007 Jul; 44(3):148-56. PubMed ID: 17631179
[TBL] [Abstract][Full Text] [Related]
7. 2nd International Symposium on Febrile Neutropenia, Brussels, 14-16 December 1995.
Hess U
Support Care Cancer; 1996 Jul; 4(4):320-1. PubMed ID: 8829314
[No Abstract] [Full Text] [Related]
8. [Antimicrobial therapy of febrile neutropenia--current developments].
Karthaus M; Cornely OA; Südhoff T; Meran J
Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
[TBL] [Abstract][Full Text] [Related]
9. A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia.
Rondinelli PI; Ribeiro Kde C; de Camargo B
J Pediatr Hematol Oncol; 2006 Oct; 28(10):665-70. PubMed ID: 17023827
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic sequential therapy for febrile neutropenia in pediatric patients with malignancy.
Bernig T; Weigel S; Mukodzi S; Reddemann H
Pediatr Hematol Oncol; 2000; 17(1):93-8. PubMed ID: 10689719
[TBL] [Abstract][Full Text] [Related]
11. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?
Karthaus M; Carratalà J; Jürgens H; Ganser A
Chemotherapy; 1998; 44(6):427-35. PubMed ID: 9755304
[TBL] [Abstract][Full Text] [Related]
12. Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Ichikawa M; Suzuki D; Ohshima J; Cho Y; Kaneda M; Iguchi A; Ariga T
Pediatr Blood Cancer; 2011 Dec; 57(7):1159-62. PubMed ID: 21438131
[TBL] [Abstract][Full Text] [Related]
13. Brucella melitensis: a rare cause of febrile neutropenia.
Citak EC; Arman D
Pediatr Hematol Oncol; 2011 Feb; 28(1):83-5. PubMed ID: 20863159
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
15. Treating low-risk febrile neutropenia: Jenny's story.
Phillips R; Skinner R; Chisholm JC
Arch Dis Child; 2007 Jan; 92(1):7-8. PubMed ID: 17185442
[TBL] [Abstract][Full Text] [Related]
16. Management of the febrile patient with cancer and neutropenia.
Buchanan GR
J Pediatr; 1992 Apr; 120(4 Pt 1):669-70. PubMed ID: 1552422
[No Abstract] [Full Text] [Related]
17. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.
Chernobelski P; Lavrenkov K; Rimar D; Riesenberg K; Schlaeffer F; Ariad S; Mermershtain W
Chemotherapy; 2006; 52(4):185-9. PubMed ID: 16675902
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
Corapcioglu F; Sarper N; Zengin E
Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
